To determine the role of miR-135a and its targets in the pathogenesis of PCa, we investigated miR-135a, RBAK and MMP11 expression levels in prostate tumors compared to normal prostate tissues using two publicly available gene expression database: GSE21036 [34] and GSE6919 [35]. The gene discussed is RBAK; the disease is posterior cortical atrophy.